SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-054860
Filing Date
2009-10-29
Accepted
2009-10-29 16:24:42
Documents
4
Period of Report
2009-10-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c91611e8vk.htm 8-K 13535
2 EXHIBIT 10.1 c91611exv10w1.htm EX-10.1 21670
3 EXHIBIT 99.1 c91611exv99w1.htm EX-99.1 76977
4 GRAPHIC c91611p9161101.jpg GRAPHIC 23774
  Complete submission text file 0000950123-09-054860.txt   146954
Mailing Address 6 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 6 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 091144903
SIC: 2834 Pharmaceutical Preparations